Movano(MOVE) - 2024 Q1 - Quarterly Results

Exhibit 99.1 First Quarter 2024 and Recent Financial Highlights Movano Health Reports Q1 2024 Financial Results and Provides Business Update Submits exemplary Sp02 clinical trial results as part of FDA 510(k) clearance process Plans launch of Evie Med and focuses on B2B opportunities Plans arterial blood pressure study for June Conference Call at 2:00 PM PT/ 5:00 PM ET Today PLEASANTON, Calif. – May 15, 2024 – Movano Health (Nasdaq: MOVE), a pioneer in health technology, reported first quarter 2024 results ...